Trombosit Hastalıkları

Authors

Sibel Demiral Sezer

Synopsis

Platelets are anucleated cells that maintain hemostasis by forming a platelet plug through adhesion, activation, and aggregation steps upon endothelial injury. Platelet disorders can be inherited, acquired, or quantitative (thrombocytopenia and thrombocytosis). While Glanzmann thrombasthenia, Bernard-Soulier syndrome, and Von Willebrand disease stand out among inherited functional disorders, acquired functional disorders are predominantly caused by medications, especially aspirin, renal failure, and liver diseases. When evaluating thrombocytopenia, defined as a circulating platelet count below 150,000/mm³, pseudothrombocytopenia caused by EDTA-dependent clumping must first be ruled out. True thrombocytopenia stems from decreased production, increased destruction (immunological/non-immunological), or abnormal distribution (hypersplenism). Immune Thrombocytopenic Purpura (ITP), an autoimmune condition, presents with spontaneous mucocutaneous bleeding due to peripheral destruction and is treated with corticosteroids, IVIG, platelet transfusions, and second-line splenectomy. Additionally, heparin-induced thrombocytopenia (HIT), Thrombotic Microangiopathies (TTP, HUS, DIC), and gestational thrombocytopenia represent significant clinical entities. Thrombocytosis, defined as a platelet count exceeding 450,000/mm³, requires differential diagnosis between reactive causes (iron deficiency, infection, inflammation) and myeloproliferative neoplasms.

References

Drews RE. Approach to the patient with a bleeding diathesis. August 20, 2005, UpToDate (14.2).

Coller BS, Schneiderman PI. Clinical Evaluation of Hemorrhagic Disorders: The Bleeding History and Differantial Diagnosis of Purpura. In: Hoffman R, Benz EJ, Shatil SJ et als, eds. Hematology Basic Pirinciples and Practices. 4th ed. Philedelphia, Elsevier Churchill Livingstone, 2005:1975-1999.

Coutre S. Congenital and acquired disorders of platelet function May 9, 2006, UpToDate (14.2).

George JN, Rizvi MA: Thrombocytopenia.Eds: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn A. Williams Hematology.6th ed. McGrawHill Co. New York. 2001; pp 1495-1539.

Levine SP: Thrombocytopenia: Pathophysiology and Classifica- tion. Ed.Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B. Wintrobe’s Clinical Hematology.11th ed. Lippincott Williams&Wilkins Co. Philadelphia. 2004; pp 1529-1532.

Ruggenenti P, Noris M, Remuzzi G. Thrombotic microangiopaty, hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Kidney Int 2001;60:831-846.

Moake J. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600.

Martinez J. Microangiopathic hemolytic anemia. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology. Sixth ed. NewYork: McGraw-Hill, 2004, 623-625.

Aledort LM, Hayward CP, Chen MG, Nichol JL, Bus- sel J.Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.Am J Hematol 2004 76(3):205-213.

Türk Hematoloji Derneği kılavuzları

Published

January 5, 2022

License

License